AUS
NZ
UK
CA
USA
IND
Highlights
- ACCC grants approval for Sigma Healthcare’s merger with Chemist Warehouse.
- Sigma commits to competitive practices and pharmacy service obligations.
- Reverse acquisition places Chemist Warehouse shareholders with a major stake.
Sigma Healthcare (ASX:SIG) has reached a significant milestone in its proposed merger with Chemist Warehouse Group (CWG) following the Australian Competition and Consumer Commission’s (ACCC) decision not to oppose the deal. The approval, which is conditional on a court-enforceable undertaking, allows Sigma to proceed with the merger, forming a substantial ASX-listed healthcare entity with an extensive pharmacy network.
The merger will see Sigma acquiring Chemist Warehouse through a reverse acquisition structure, with Chemist Warehouse shareholders gaining a majority stake of 85.75% in the combined company. In addition to issuing shares, Sigma will pay $700 million in cash to complete the transaction. Sigma’s CEO, Vikesh Ramsunder, noted that the ACCC’s decision marks a “critical milestone” in the merger, expressing optimism about the potential to establish a leading presence in the Australian healthcare market.
The ACCC’s review concluded that this merger is unlikely to significantly reduce competition within the industry. Factors contributing to this decision include the presence of other major pharmaceutical wholesalers, such as Australian Pharmaceutical Industries (API) and EBOS Group (ASX:EBO). ACCC Chair Gina Cass-Gottlieb emphasized that pharmacies have other wholesale options, which helps maintain a competitive landscape. The ACCC also considered the ease with which pharmacies can switch suppliers, reducing concerns over market concentration.
As part of the court-enforceable undertaking, Sigma has committed to maintaining fair business practices post-merger. Key elements of this undertaking include allowing pharmacies under long-term contracts to exit their agreements without excessive fees or penalties. Sigma has also pledged to protect pharmacy data, ensuring privacy and security standards are upheld.
Additionally, the merged entity is committed to fulfilling the Commonwealth Government’s Community Service Obligations for five years. This commitment aims to ensure the reliable supply of essential medicines under the Pharmaceutical Benefits Scheme (PBS) across Australia, further reinforcing Sigma’s dedication to serving public health needs.
Through these measures, Sigma seeks to balance its expansion ambitions with a strong commitment to competitive and responsible practices. The merger with Chemist Warehouse is positioned to bring significant operational synergies and bolster the healthcare services provided to communities nationwide.
